. Portulaca oleracea (purslane), is an annual green herbaceous medicinal plant widespread in temperate and tropical regions of the world (Yang et al., 2009 ). The pharmacological potential of the Portulaca oleracea, such as anti-inflammatory (Chan et al., 2000) , antioxidative (Dkhil et al., 2011) , anti-bacterial (Zhang et al., 2002) , skeletal muscle relaxant (Parry et al., 1993) , woundhealing (Rashed et al., 2003) , and in vitro anti-tumor (Yoon et al., 1999) activities have been reported. The Petroselinum sativum (PS) or parsley, a member of the family of Umbelliferae, has also been reported to have antioxidant (Kreydiyyeh et al., 2001; Ahmed et al., 2010) , antidiabetic (Yanardag et al., 2003) , anti-inflammatory, antiedema antihypertensive, antimicrobial (Wahba et al., 2010) activities. Recently we have also reported that seed and oil extracts of Petroselinum sativum induced cytotoxicity against human breast cancer cells .
Due to the diverse pharmacological and preventive properties of these plant extracts, present investigation was carried out to screen the anticancer activity of seed extracts of Petroselinum sativum and Portulaca oleracea against hepatocarcinoma cells (HepG2). The HepG2 cell line has been well established in vitro model for anti hepatocellular carcinoma (Li et al., 2014) .
Materials and Methods

Chemicals and consumables
Dulbecco's Modified Eagle's Medium (DMEM) culture medium, antibiotics-atimycotic solution, fetal bovine serum (FBS) and trypsin were purchased from Invitogen, Life Sciences, USA. Consumables and culture wares used in the study were procured from Nunc, Denmark. All other specified reagents and solvents were purchased from Sigma Chemical Company Pvt. Ltd. St. Louis, MO, USA.
Plant material and extractions
The seeds of Portulaca oleracea and Petroselinum sativum and used in this study were obtained from the local market of Riyadh, Saudi Arabia. The seeds were screened manually to remove bad ones. For the preparation of alcoholic extract, the seeds were macerated in alcohol and then filtered. The procedure was repeated several times. The solvent was then evaporated using a rotary evaporator and the residue so obtained was called as the alcoholic extract.
Cell culture
HepG2, human hepatocellular carcinoma cells were cultured in DMEM, supplemented with 10% FBS, 0.2% sodium bicarbonate and antibiotic/antimycotic solution (100x, 1ml/100 ml of medium). Cells were grown in 5% CO 2 at 37 o C in high humid atmosphere. Before the experiments, viability of cells was assessed following the protocol of (Siddiqui et al., 2008) . HepG2 cells showing more than 98% cell viability and passage number between 20 and 22 were used in the present study.
Experimental design
HepG2 cells were exposed to various concentrations (5-500 μg/ml) of seed extracts of Portulaca oleracea and Petroselinum sativum for a period of 24 h. Following the exposures, HepG2 cells were subjected to assess the cytotoxic responses using 3-(4, 5-dimethylthiazol-2yl)-2, 5-biphenyl tetrazolium bromide (MTT), neutral red uptake (NRU) assay, and cellular morphology by phase contrast inverted microscope.
Drug solutions
The Portulaca oleracea and Petroselinum sativum extracts were not completely soluble in aqueous medium, therefore the stock solutions of all the extracts were prepared in dimethylsulphoxide (DMSO) and diluted in culture medium to reach the desired concentrations. The concentration of DMSO in culture medium was not more that 0.1% and this medium was used as control.
Cytotoxicity screening
MTT assay: Cell viability was assessed using the 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide (MTT) assay as described (Siddiqui et al., 2008) . Briefly, HepG2 cells (1x104) were allowed to adhere for 24 h CO2 incubator at 37°C in 96 well culture plates. After the respective exposure, MTT (5 mg/ml of stock in PBS) was added (10 μl/well in 100 μl of cell suspension), and plates were incubated for 4 h. Then, supernatants were discarded and 200 μl of DMSO were added to each well and mixed gently. The developed color was read at 550 nm using multiwell microplate reader (Thermo Scientific, USA). Untreated sets were also run under identical conditions and served as control.
Neutral red uptake (NRU) assay
Neutral red uptake (NRU) assay was carried out following the protocol (Siddiqui et al., 2010) . Briefly, after the exposure, the medium was aspirated and cells were washed twice with PBS, and incubated for 3 h in a medium supplemented with neutral red (50 μg/ml). Medium was washed off rapidly with a solution containing 0.5% formaldehyde and 1% calcium chloride. Cells were subjected to further incubation of 20 min at 37 o C in a mixture of acetic acid (1%) and ethanol (50%) to extract the dye. The plates were read at 540 nm using multiwell microplate reader (Thermo Scientific, USA). The values were compared with the control sets run under identical conditions.
Morphological analysis
Morphological changes in HepG2 cells exposed to increasing concentrations (5-500 μg/ml) of PO and PS extracts were taken using an inverted phase contrast microscope (OLYMPUS CKX 41) at 20 X magnification.
Statistical analysis
The results were expressed as mean and standard error of means (SEM). One way ANOVA was employed to detect differences between the groups of treated and control. The values showing p<0.05 were considered as statistically significant.
Results
Cytotoxicity assessments by MTT and NRU assay
The cytotoxicity assessments by MTT and NRU assay in HepG2 cells exposed to PO extract are summarized in Figure 1 and 2. HepG2 cells were exposed to various concentrations (5-500 μg/ml) of PO for 24 h. Results showed that PO induced statistically significant (p<0.001) decrease in the cell viability of HepG2 cells in a concentration dependent manner. The HepG2 cells exposed to PO at 50 μg/ml and higher concentrations were found to be cytotoxic. The cell viability was recorded as 67%, 31%, 21%, and 17% at 50, 100, 250, and 500 μg/ml of PO, respectively by MTT assay (Figure 1 ) and 91%, 62%, 27%, and 18% at 50, 100, 250, and 500 μg/ml of PO, respectively by NRU assay (Figure 2 ). HepG2 cells exposed to PS extract at various concentrations (5-500 μg/ml) for 24 h also exhibit the DOI:http://dx.doi.org/10.7314/APJCP.2014.15.16 Figure  4 and 5). PS exposed HepG2 cells with 100 μg/ml and higher concentrations decreased the cell viability. The decrease in the cell viability at 100, 250, and 500 μg/ ml of PS was recorded as 70%, 33%, and 15% by MTT assay (Figure 4) and 63%, 29%, and 17% by NRU assay (Figure 5 ), respectively. The PO and PS at 25 μg/ml and lower concentrations did not show any decrease in the cell viability of HepG2 cells as observed by MTT and NRU assays. The PO extract was found to be more cytotoxic to HepG2 cells as compared to PS extract.
Morphological changes
The morphological changes observed in HepG2 cells are shown in Figures 3 and 6 . Alterations in the morphology of HepG2 cells exposed to PO and PS were found in a concentration dependent manner. Cells exposed to 50 μg/ml and higher concentrations of PO for 24 h lose the normal morphology and cell adhesion capacity of at 20 X magnification Control 5 µg/ml 10 µg/ml 25 µg/ml 50 µg/ml 100 µg/ml 500 µg/ml 250 µg/ml HepG2 cells as compared to control (Figure 3 ). However, PS at 100 μg/ml and higher concentrations lose the normal morphology and cell adhesion capacity of HepG2 cells as compared to control. Most of cells at higher concentrations appeared rounded in the shape ( Figure 6 ). The PO and PS at 25 μg/ml and lower concentration did not effect on the morphology of HepG2 cells.
Discussion
Several studies demonstrate that traditional medicine could be a promising source in the development of a potential therapeutic anticancer drug (Pan and Ho, 2008; Al-Oqail et al., 2013; Farshori et al., 2013 , Al-Sheddi et al., 2014 . Herbal medicines have long been viewed as a source of curative remedy based on religious and cultural traditions (Ghazanfer, 1994; Pal and Shukla, 2003; Saetung et al., 2005) . Portulaca oleracea (purslane), is well known for its preventive and pharmacological potential, such as anti-inflammatory (Chan et al., 2000) , antioxidative (Dkhil et al., 2011; Erkan et al., 2012) , anti-bacterial (Zhang et al., 2002) activities. Thus, in order to provide comparative data on in vitro anticancer activity of the extracts of Portulaca oleracea (PO) and Petroselinum sativum (PS) on human hepatocellular carcinoma cell lines (HepG2), the present study was designed. The cytotoxicity of PO and PS extracts were observed by MTT and NRU assays. The results indicated that PO and PS seed extracts decreased the cell viability of HepG2 cells in a concentration-dependent manner. The study demonstrated that 50-500 μg/ml of PO and 100-500 of PS concentrations significantly (p<0.01) decreased the cell viability. Our results are in accordance with the previous studies showing v anticancer activity of PO at 50-500 μg/ml concentrations against the human cervical cancer (HeLa) and the mouse cervical carcinoma (U14) cells (Zhao et al., 2013) . The protective potential of PO against Ehrlich ascites carcinoma bearing albino mice have also been reported (Ali et al., 2014) . Our results from present study suggest that the cytotoxicity of the PO might be due to free radical scavenging property of extract in the presence of antioxidant phytochemicals (Han et al., 2003; Peksel et al., 2006; Ebrahimzadeh et al., 2009) and the presence of active compounds (Huang and Zou, 2011; Kma, 2013) , which is showing anticancer activity on HepG2 cells. Studies also showed that constitutes of various plant extracts also inhibit the growth of other cancerous cells (Li et al., 1995; Kim et al., 2002; KumiDiaka and Butler, 2000) . Recently, we have also shown that plant extracts decreased the cell viability of various cancer cells, including human epidermoid cancer cells (HEp2), human breast adenocarcinoma cells (MCF-7), human amniotic epithelial cells (WISH), and human lung cancer cells , Al-Sheddi et al., 2014 . The alterations in the morphology of HepG2 exposed to various concentrations of seed extracts of PO and PS observed by phase contrast inverted microscope showed the detachment of the cells with the increasing concentrations. These kinds of alterations in the cellular morphology induced by plant extracts at higher concentration have also been reported (Berrington and Lall, 2012; Al-Oqail et al., 2013 , Al-Sheddi et al., 2014 .
Our results also showed that PS extract significantly decreased the cell viability of HepG2 in a concentration dependent manner. The antioxidant (Kreydiyyeh et al., 2001; Ahmed et al., 2010) , antidiabetic (Yanardag et al., 2003) , anti-inflammatory, antiedema antihypertensive, and antimicrobial (Wahba et al., 2010) activities of PS extracts have previously been reported. Our results are in well correspondence with the previous findings of anticancer activity of seed extract of PS against MCF-7 cells . Many studies have also shown that this kind of effects towards cancerous cells may be due to the presence of bioactive components such as, polysaccharides, flavonoids, coumarins, monoterpene glycoside and alkaloids in these plant extracts (Xiang et al., 2005 , Xin et al., 2008 , Li et al., 2009 , Tan et. al., 2013 . Various plant extracts have also been found to induce cytotoxicity on human breast cancer T47D cells (Abdolmohammadi et al., 2008) , human gastric adenocarcinoma (MK-1), human uterus carcinoma (HeLa), and murine melanoma (B16F10) cells (Fujika et al., 1999) . Recently, we have also shown that PS seed extracts decreased the cell viability of human breast cancer cells (MCF-7) . The PO extract showed higher cytotoxicity in HepG2 cells as compared to the PS extract. The difference in the response of plant extracts towards the HepG2 cells could be due to the presence of active components (Samarakoon et al., 2010) Control 5 µg/ml 10 µg/ml 25 µg/ml 500 µg/ml 250 µg/ml 100 µg/ml 50 µg/ml and flavanoids (Das et al., 2010) .
In conclusion, our results showed that Portulaca oleracea (PO) and Petroselinum sativum (PS) extracts significantly reduced the cell viability, and altered the cellular morphology of HepG2 cells in a concentration dependent manner. The data also revealed that HepG2 cells were more sensitive to PO than the PS extract. Further molecular studies are undergoing to elucidate the mechanism(s) of action of these extracts on human hepatocellular carcinoma cells.
